1. Research Objectives and Assumptions

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Therapy Type
     • Market Snippet, By Route of Administration
     • Market Snippet, By Distribution Channel
     • Market Snippet, By Country
   • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Market Trends
   • Key Developments
   • Recent Product Launch/Approval
   • Key Strategies Adopted by Market Players
   • PEST Analysis
   • Epidemiology
   • Mergers and Acquisitions

4. LATAM Fabry Disease Market, By Therapy Type, 2021 – 2033, (USD Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2021 – 2033
     • Segment Trends
   • Enzyme Replacement Therapy
     • Agalsidase Beta (Fabrazyme)
     • Agalsidase Alfa (Replagal)
     • Pegunigalsidase Alfa (PRX-102, Phase III)
       • Introduction
       • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
   • Chaperon Therapy
     • Migalastat (Galafold Phase III)
       • Introduction
       • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
   • Substrate Reduction Therapy
     • Lucerastat (Phase III)
     • Venglustat (Phase III)
       • Introduction
       • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)

5. LATAM Fabry Disease Market, By Route of Administration, 2021 – 2033, (USD Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2021 – 2033
     • Segment Trends
   • Oral
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
   • Parenteral
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)

6. LATAM Fabry Disease Market, By Distribution Channel, 2021 – 2033, (USD Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2021 – 2033
     • Segment Trends
   • Hospitals Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
   • Online pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)

7. LATAM Fabry Disease Market, By Country, 2021 – 2033, (USD Mn)

   • Introduction
     • Market Share Analysis, By Country, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, For Country, 2020 – 2033
   • Latin America
     • Brazil
       • Market Size and Forecast, By Therapy Type, 2021 – 2033, (USD Mn)
       • Market Size and Forecast, By Route of Administration, 2021 – 2033, (USD Mn)
       • Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Mn)
     • Mexico
       • Market Size and Forecast, By Therapy Type, 2021 – 2033, (USD Mn)
       • Market Size and Forecast, By Route of Administration, 2021 – 2033, (USD Mn)
       • Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Mn)
     • Argentina
       • Market Size and Forecast, By Therapy Type, 2021 – 2033, (USD Mn)
       • Market Size and Forecast, By Route of Administration, 2021 – 2033, (USD Mn)
       • Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Mn)
     • Rest of Latin America
       • Market Size and Forecast, By Therapy Type, 2021 – 2033, (USD Mn)
       • Market Size and Forecast, By Route of Administration, 2021 – 2033, (USD Mn)
       • Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Mn)

8. Competitive Landscape

   • Heat Map Analysis
   • Market Share Analysis
     • Amicus Therapeutics, Inc.
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Sanofi-Aventis U.S. LLC
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • GlaxoSmithKline plc
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Mendelics
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Takeda Pharmaceuticals U.S.A., Inc.
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Teva pharmaceutical Industries Ltd
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Pfizer Inc.
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Novartis AG
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Moderna Therapeutics Inc
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Resverlogix
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
   • Analyst Views

9. Section

   • References
   • Research Methodology
   • About Us and Sales Contact